Autoantibodies to murine type II collagen in collagen-induced arthritis - A comparison of susceptible and nonsusceptible strains

被引:0
|
作者
Brand, DD
Marion, TN
Myers, LK
Rosloniec, EF
Watson, WC
Stuart, JM
Kang, AH
机构
[1] UNIV TENNESSEE,DEPT MED,MEMPHIS,TN 38104
[2] UNIV TENNESSEE,DEPT MICROBIOL & IMMUNOL,MEMPHIS,TN 38104
[3] UNIV TENNESSEE,DEPT PEDIAT,MEMPHIS,TN 38104
来源
JOURNAL OF IMMUNOLOGY | 1996年 / 157卷 / 11期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Collagen-induced arthritis (CIA) is an experimental autoimmune disease elicited in genetically susceptible strains of mice by immunization with heterologous type II collagen. This experimental disease is mediated by the immune response of both T cells and B cells, and susceptibility is restricted by the class II molecules of the MHC. In this study we identify specific epitopes bound by autoantibodies elicited through immunization of several haplotypes of C57BL/10 mice with chick alpha 1(II)-CB11. ELISA analysis using a panel of 15-mer murine type II collagen peptides revealed a pattern of autoantibody epitope specificity that was remarkably similar among CIA-susceptible and nonsusceptible congenic strains, regardless of class II haplotype. However, one epitope was identified that was bound only by autoantibodies from CIA-susceptible strains bearing I-A(q)(B10.Q and B10.Q beta BR). In addition, this epitope was also present within affinity-purified Ab obtained from the CIA-susceptible strain DBA/1 (I-A(q)). Analyses of immune serum from B10.Q and B10.Q beta BR mice revealed that a subset of the antibodies binding this epitope were of the IgG2 subclass, and therefore efficient at fixing complement, a requirement for pathogenicity of the Abs in CIA.
引用
收藏
页码:5178 / 5184
页数:7
相关论文
共 50 条
  • [41] Changes in gene expression on the type II collagen-induced arthritis in rats
    Katayama, S
    Oobuchi, S
    Kyoku, S
    Yamashita, Y
    Unakami, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 185P - 185P
  • [42] EFFECT OF ACTARIT ON TYPE-II COLLAGEN-INDUCED ARTHRITIS IN MICE
    FUJISAWA, H
    NISHIMURA, T
    MOTONAGA, A
    INOUE, Y
    INOUE, K
    SUZUKA, H
    YOSHIFUSA, H
    KIMURA, K
    MURAMATSU, M
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1994, 44-1 (01): : 64 - 68
  • [43] THE EFFECT OF ETODOLAC ON TYPE-II COLLAGEN-INDUCED ARTHRITIS IN MICE
    WOOLEY, PH
    WHALEN, JD
    ZIMMERMAN, JL
    CHAMPION, TM
    AGENTS AND ACTIONS, 1987, 21 (3-4): : 244 - 246
  • [44] The influence of silicone implantation on type II collagen-induced arthritis in mice
    Schaefer, CJ
    Whalen, JD
    Knapp, T
    Wooley, PH
    ARTHRITIS AND RHEUMATISM, 1997, 40 (06): : 1064 - 1072
  • [45] THE ROLE OF NEUTROPHILS IN TYPE-II COLLAGEN-INDUCED ARTHRITIS IN RATS
    SCHRIER, D
    GILBERTSEN, RB
    LESCH, M
    FANTONE, J
    AMERICAN JOURNAL OF PATHOLOGY, 1984, 117 (01): : 26 - 29
  • [46] EFFECT OF ETODOLAC ON TYPE-II COLLAGEN-INDUCED ARTHRITIS IN MICE
    INOUE, K
    MOTONAGA, A
    SUZUKA, H
    YOSHIFUSA, H
    FUJISAWA, H
    NISHIMURA, T
    INOUE, Y
    UEDA, F
    SHIBATA, Y
    KIMURA, K
    AGENTS AND ACTIONS, 1993, 39 (3-4): : 187 - 194
  • [47] Gallium nitrate ameliorates type II collagen-induced arthritis in mice
    Choi, Jae-Hyeog
    Lee, Jong-Hwan
    Roh, Kug-Hwan
    Seo, Su-Kil
    Choi, Ii-Whan
    Park, Sae-Gwang
    Lim, Jun-Goo
    Lee, Won-Jin
    Kim, Myoung-Hun
    Cho, Kwang-rae
    Kim, Young-Jae
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 20 (01) : 269 - 275
  • [48] TYPE-II COLLAGEN-INDUCED ARTHRITIS IN RATS - THE ROLE OF NEUTROPHILS
    SCHRIER, DJ
    GILBERTSEN, RB
    LESCH, M
    FANTONE, J
    FEDERATION PROCEEDINGS, 1984, 43 (03) : 782 - 782
  • [49] Phenotypic characterization of type II collagen-induced arthritis in Wistar rats
    Song, Hou-Pan
    Li, Xin
    Yu, Rong
    Zeng, Guang
    Yuan, Zhen-Yi
    Wang, Wei
    Huang, Hui-Yong
    Cai, Xiong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (04) : 1483 - 1488
  • [50] THE INFLUENCE OF DIET ON TYPE-II COLLAGEN-INDUCED ARTHRITIS IN MICE
    WOOLEY, PH
    LUTHRA, HS
    HUSE, A
    STUART, JM
    DAVID, CS
    CLINICAL RESEARCH, 1984, 32 (04): : A825 - A825